Drug Shortage Report for MYLAN-IRBESARTAN
| Report ID | 9210 |
| Drug Identification Number | 02347326 |
| Brand name | MYLAN-IRBESARTAN |
| Common or Proper name | IRBESARTAN |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | IRBESARTAN |
| Strength(s) | 300MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 90BT |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-07-19 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2017-10-02 |
| Shortage status | Resolved |
| Updated date | 2017-10-03 |
| Company comments | Discontinuation reported under ID 20271. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2017-10-03 | English | Compare |
| v5 | 2017-10-02 | French | Compare |
| v4 | 2017-10-02 | English | Compare |
| v3 | 2017-07-20 | English | Compare |
| v2 | 2017-05-05 | French | Compare |
| v1 | 2017-05-05 | English | Compare |
Showing 1 to 6 of 6